Status:
COMPLETED
Tanezumab In Osteoarthritis Of The Knee (2)
Lead Sponsor:
Pfizer
Conditions:
Arthritis
Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis.
Eligibility Criteria
Inclusion
- Osteoarthritis of the knee according to Kellgren-Lawrence x-ray grade of 2
Exclusion
- Pregnancy or intent to become pregnant
- BMI greater than 39
- other severe pain, significant cardiac, neurologic or cardiac disease
Key Trial Info
Start Date :
May 5 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2010
Estimated Enrollment :
832 Patients enrolled
Trial Details
Trial ID
NCT00830063
Start Date
May 5 2009
End Date
August 31 2010
Last Update
May 13 2021
Active Locations (94)
Enter a location and click search to find clinical trials sorted by distance.
1
Anniston Medical Clinic, PC
Anniston, Alabama, United States, 36207
2
Pinnaccle Research Group, LLC
Anniston, Alabama, United States, 36207
3
Clinical Research Advantage, Inc. / Mesa Family Medical Center, PC
Mesa, Arizona, United States, 85203
4
Arizona Arthritis & Rheumatology Associates, P.C.
Paradise Valley, Arizona, United States, 85253